drugset
drugset / Trial / NCT04013191

A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants

NCT04013191 ↗

Phase 1 Completed 28 enrolled UCB Biopharma S.P.R.L.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of the study is to evaluate the plasma pharmacokinetic of padsevonil in adult and elderly study participants.

Timeline

Start
2019-07-09
Primary completion
2019-10-03
Completion
2019-10-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Padsevonil Small molecule — —

Indications

No indication recorded.